PBE vs. PILL ETF Comparison

Comparison of PowerShares Dynamic Biotech & Genome (PBE) to Direxion Daily Pharmaceutical & Medical Bull 3X Shares ETF (PILL)
PBE

PowerShares Dynamic Biotech & Genome

PBE Description

The PowerShares Dynamic Biotechnology & Genome Portfolio (Fund) is based on the Dynamic Biotech & Genome IntellidexSM Index (Intellidex Index). The Fund will normally invest at least 90% of its total assets in common stocks that comprise the Index. The Intellidex Index is designed to provide capital appreciation by thoroughly evaluating companies based on a variety of investment merit criteria, including price momentum, earnings momentum, quality, management action, and value. The Underlying Intellidex Index is comprised of common stocks of 30 US biotechnology and genome companies. These are companies that are principally engaged in the research, development, manufacture and marketing and distribution of various biotechnological products, services and processes and companies that benefit significantly from scientific and technological advances biotechnology and genetic engineering and reseach. The Fund and the Index are rebalanced and reconstituted quarterly in February, May, August and November.

Grade (RS Rating)

Last Trade

$67.96

Average Daily Volume

6,297

Number of Holdings *

30

* may have additional holdings in another (foreign) market
PILL

Direxion Daily Pharmaceutical & Medical Bull 3X Shares ETF

PILL Description The investment seeks daily investment results, before fees and expenses, of 300% of the daily performance of the S&P Pharmaceuticals Select Industry Index. The fund invests at least 80% of its net assets in financial instruments, such as swap agreements, securities of the index, and ETFs that track the index and other financial instruments that provide daily leveraged exposure to the index or to ETFs that track the index. The index is a modified equal-weighted index that is designed to measure performance of the stocks comprising the S&P Total Market Index that are classified in the GICS pharmaceuticals sub-industry. The fund is non-diversified.

Grade (RS Rating)

Last Trade

$8.96

Average Daily Volume

51,627

Number of Holdings *

44

* may have additional holdings in another (foreign) market
Performance
Period PBE PILL
30 Days -0.79% -4.48%
60 Days -4.76% 6.92%
90 Days -4.75% 10.21%
12 Months 19.90% 67.40%
1 Overlapping Holdings
Symbol Grade Weight in PBE Weight in PILL Overlap
COLL F 2.27% 1.0% 1.0%
PBE Overweight 29 Positions Relative to PILL
Symbol Grade Weight
UTHR C 5.74%
ILMN C 5.64%
ALNY D 4.78%
AMGN F 4.7%
BIIB F 4.21%
NBIX C 4.18%
XNCR B 3.88%
EXEL B 3.86%
TGTX B 3.78%
BMRN F 3.76%
MNKD C 3.7%
NTRA A 3.56%
REGN F 3.38%
INCY C 3.35%
VCYT B 3.28%
ACAD C 3.06%
CPRX C 3.0%
BPMC B 2.91%
TECH F 2.89%
VCEL A 2.79%
OPK C 2.78%
RGEN D 2.76%
PTGX D 2.75%
QGEN D 2.59%
BCRX D 2.56%
HALO F 2.42%
CDNA D 1.92%
NVAX F 1.83%
MYGN F 1.61%
PBE Underweight 43 Positions Relative to PILL
Symbol Grade Weight
CORT B -3.39%
BMY B -2.69%
LBPH A -2.67%
ITCI C -2.63%
JAZZ C -2.63%
VTRS B -2.48%
AXSM B -2.38%
EWTX C -2.38%
CTLT C -2.22%
ELAN D -2.18%
PRGO C -2.13%
RPRX D -2.1%
JNJ C -2.06%
ZTS D -2.04%
PFE F -2.0%
LLY F -1.98%
MRK D -1.9%
TARS C -1.86%
ARVN F -1.73%
OGN F -1.7%
SAVA C -1.68%
PBH A -1.6%
SUPN C -1.46%
AMPH F -1.39%
PCRX C -1.27%
LGND C -1.2%
ANIP F -1.04%
OCUL D -1.0%
AMRX C -0.89%
HROW D -0.88%
HRMY F -0.84%
WVE C -0.8%
MNMD C -0.78%
INVA D -0.67%
EYPT D -0.65%
LQDA F -0.61%
FULC F -0.6%
PLRX D -0.6%
ELVN D -0.45%
NUVB C -0.4%
EOLS D -0.36%
PHAT F -0.33%
XERS C -0.31%
Compare ETFs